Fidelis Capital Partners, LLC Insmed Inc Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Insmed Inc stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 1,270 shares of INSM stock, worth $96,481. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,270Holding current value
$96,481% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding INSM
# of Institutions
349Shares Held
140MCall Options Held
2.25MPut Options Held
3.11M-
Vanguard Group Inc Valley Forge, PA14.5MShares$1.1 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$896 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$818 Million0.04% of portfolio
-
State Street Corp Boston, MA5.91MShares$449 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.78MShares$363 Million4.29% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.3B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...